Literature DB >> 10656711

Frequency of specific anti-Toxoplasma gondii IgM, IgA and IgE in colombian patients with acute and chronic ocular toxoplasmosis.

J E Gómez-Marín1, M T Montoya-De-Londoño, J C Castaño-Osorio, F A Heine, A M Duque, C Chemla, D Aubert, A Bonhomme, J M Pinon.   

Abstract

We studied the frequency of specific anti-Toxoplasma IgM, IgA and IgE antibodies in serum of 28 immunocompetent Colombian patients, selected by ophthalmologists and with lesions that were compatible with ocular toxoplasmosis. Patients were classified in three groups: (i) group 1 consisted of ten patients with a first episode; (ii) group 2, with seven patients with a recurrence and (iii) group 3, consisted of eleven patients with chronic chorioretinal lesion without uveitis. We found that 10/28 (35%) of Colombian patients with ocular toxoplasmosis possessed at least one serological marker for Toxoplasma infection different from IgG. In group 1 (first episode), we found simultaneous presence of specific IgM plus IgA plus IgE in 1/10 (10%). In group 2 (recurrences) in 1/7 (14%) we found IgM and IgA test positives and in 1/7 (14%) we found IgM and IgE tests positives. In group 3 (toxoplasmic chorioretinal scar) the IgA serological test was positive in 2/11 (18%). These results show that serum IgM or IgA or IgE can be present during recurrences.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10656711     DOI: 10.1590/s0074-02762000000100014

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  5 in total

1.  Aqueous humor and serum immunoblotting for immunoglobulin types G, A, M, and E in cases of human ocular toxoplasmosis.

Authors:  Justus G Garweg; Silvia-Daniela L Garweg; Franziska Flueckiger; Patrick Jacquier; Matthias Boehnke
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

2.  Clinical manifestation and prognosis of active ocular toxoplasmosis in Iran.

Authors:  Farzan Kianersi; Afsaneh Naderi Beni; Zahra Naderi Beni
Journal:  Int Ophthalmol       Date:  2012-06-26       Impact factor: 2.031

3.  Ocular cytokinome is linked to clinical characteristics in ocular toxoplasmosis.

Authors:  Alejandra de-la-Torre; Alexander W Pfaff; Michael E Grigg; Odile Villard; Ermanno Candolfi; Jorge E Gomez-Marin
Journal:  Cytokine       Date:  2014-04-16       Impact factor: 3.861

4.  Toxoplasma gondii Elongation Factor 1-Alpha (TgEF-1α) Is a Novel Vaccine Candidate Antigen against Toxoplasmosis.

Authors:  Shuai Wang; Zhenchao Zhang; Yujian Wang; Javaid A Gadahi; Lixin Xu; Ruofeng Yan; Xiaokai Song; Xiangrui Li
Journal:  Front Microbiol       Date:  2017-02-13       Impact factor: 5.640

5.  Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha.

Authors:  Shuai Wang; YuJian Wang; XiaoNi Sun; ZhenChao Zhang; TingQi Liu; Javaid Ali Gadahi; Ibrahim Adam Hassan; LiXin Xu; RuoFeng Yan; XiaoKai Song; XiangRui Li
Journal:  BMC Infect Dis       Date:  2015-10-24       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.